Urinary Tract Infection Treatment Market Size And Share

  • Report Code : TIPRE00005931
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Urinary Tract Infection Treatment Market Share, Size, and Outlook by 2031

Buy Now

Urinary Tract Infection Treatment Market Report Urinary Tract Infection Treatment Market Scope and Analysis Urinary Tract Infection Treatment Market Size and Share

Urinary Tract Infection Treatment Market: Strategic Insights

Urinary Tract Infection Treatment Market

  • CAGR (2023 - 2031)
    3.2%
  • Market Size 2023
    US$ 10.10 Billion
  • Market Size 2031
    US$ 13.02 Billion

Market Dynamics

GROWTH DRIVERS
  • Growing prevalence of UTIs and Advancements in molecular diagnostics technologies
FUTURE TRENDS
  • Increasing R&D Activities
OPPORTUNITIES
  • Development of novel alternative treatments such as nutritional supplements for UTI

Key Players

  • Almirall SA
  • Dr Reddys Laboratories Ltd
  • Allergan
  • GlaxoSmithKline PLC
  • Shionogi Co Ltd
  • Novartis AG
  • Pfizer
  • Merck Co Inc
  • Bristol Myers Squibb Company
  • Regeneron Pharmaceuticals

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Drug Class
  • Penicillin and Combinations
  • Quinolones
  • Cephalosporin
  • Aminoglycoside Antibiotics
  • Sulphonamides
  • Nutritional Supplements
Indication
  • Complicated Urinary Tract Infection and Uncomplicated Urinary Tract Infection
Distribution Channel
  • Hospital Pharmacies
  • Gynaecology and Urology Clinics
  • Retail Pharmacies and Drug Stores
  • Online Drug Stores